Overview

In the highly competitive Life Sciences sector companies and institutions can’t afford to be constrained by inflexible, static technology infrastructures.

For clinical, pharmaceutical, and biotechnology enterprises, performance is hampered when forced to choose between speed and accuracy; or trade competitiveness for profitability. High Performance Computing (HPC) allows companies in the industry to increase collaboration among researchers, streamline and replicate processes, enhance service levels and accelerate processing for faster time-to-market. 

Whether you are working to translate genomic information into useful new discoveries, or researching new products to enhance patient care, you face a number of technical challenges and organizational demands. Increased data volume and complexity, increased regulatory and market pressures, and budgetary limitations are just a sampling of the challenges you face. HPC infrastructure software offers a path to staying competitive. 

The Platform Advantage

Accelerate drug discovery and development applications, solve new scientific or business problems, and improve research collaboration and productivity. At the same time, free your researchers, scientists and testers from technology constraints while enhancing service levels and reducing costs with Platform's HPC infrastructure software solutions.

• Support and nurture the discovery process
• Establish a single, integrated computing environment
• Eliminate costly and resource-intensive dropouts during in silico simulations and testing
• Measure the impact of informatics on overall business objective
• Access and unify globally dispersed applications and hardware
• Extend HPC across all desktops, servers, and compute clusters